A new study published in the Journal of Medicinal Chemistry suggests that a novel vaccine candidate can protect against fentanyl and its many illicit variants by training the immune system to recognize a broad molecular signature rather than a single specific structure. These findings provide evidence that next-generation drug vaccines could outpace the rapid development of synthetic designer opioids.
Only for Supporters
To read the rest of this article and access other paid content, you must be a supporter
